|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07C 311/19 | |
| C07C 311/29 | |||
| C07C 311/42 | |||
| C07C 311/46 | |||
| C07C 311/47 | |||
| C07D 213/42 | |||
| C07D 295/12 | |||
| A61K 31/18 | |||
| A61P 9/00 |
| (11) | Patento numeris | 2001838 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07759421.6 |
| Europos patento paraiškos padavimo data | 2007-03-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-12-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-03-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/064973 |
| Data | 2007-03-27 |
| (87) | Numeris | WO 2007/117981 |
| Data | 2007-10-18 |
| (30) | Numeris | Data | Šalis |
| 786891 P | 2006-03-29 | US |
| (72) |
PUSATERI, Erin, E., US
TOMMASI, Ruben, Alberto, US
LEUTERT, Thomas, CH
GROB, Jonathan, E., US
HONDA, Ayako, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Novartis Pharma GmbH, Brunner Strasse 59, 1230 Wien, AT |
| (54) | SELECTIVE HYDROXAMATE BASED MMP INHIBITORS |
| SELECTIVE HYDROXAMATE BASED MMP INHIBITORS |